Brian M. Strem

CIK: 0001876429

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KPRX

KIORA PHARMACEUTICALS INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

KPRX
KIORA PHARMACEUTICALS INC
Jul 1, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $2.66$5K
KPRX
KIORA PHARMACEUTICALS INC
Apr 1, 2026
Tax Payment(F)
Direct
1.9K shares at avg. $1.95$4K
KPRX
KIORA PHARMACEUTICALS INC
Mar 6, 2026
Award(A)
Direct
16.7K shares-
KPRX
KIORA PHARMACEUTICALS INC
Mar 3, 2026
Tax Payment(F)
Direct
238 shares at avg. $2.02$480.76
KPRX
KIORA PHARMACEUTICALS INC
Apr 1, 2025
Award(A)
Direct
15.9K shares-

		Type	Shares	Price		Ownership
Jul 1, 2026	KPRX KIORA PHARMACEUTICALS INC	Tax Payment(F)	1,869	$2.66	$4,972	Direct
Apr 1, 2026	KPRX KIORA PHARMACEUTICALS INC	Tax Payment(F)	1,906	$1.95	$3,717	Direct
Mar 6, 2026	KPRX KIORA PHARMACEUTICALS INC	Award(A)	16,733	-	$0	Direct
Mar 3, 2026	KPRX KIORA PHARMACEUTICALS INC	Tax Payment(F)	238	$2.02	$481	Direct
Apr 1, 2025	KPRX KIORA PHARMACEUTICALS INC	Award(A)	15,941	-	-	Direct

1-5 of 5 transactions

About Strem Brian M.

Strem Brian M. (SEC CIK 0001876429) files insider reports with the SEC as President and CEO of KIORA PHARMACEUTICALS INC (KPRX).

Signal8 holds 5 ownership filings by Strem Brian M., all Form 4s, filed between Apr 2, 2025 and Jul 2, 2026. Those filings report 5 transactions, from Apr 1, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Strem Brian M.'s filings is in ENCINITAS, CA.

Recent filings by Strem Brian M.

Jul 1, 2026: Tax withholding of KPRX shares (Form 4, code F).
Apr 1, 2026: Tax withholding of KPRX shares (Form 4, code F).
Mar 6, 2026: Grant or award of KPRX shares (Form 4, code A).
Mar 3, 2026: Tax withholding of KPRX shares (Form 4, code F).
Apr 1, 2025: Grant or award of KPRX shares (Form 4, code A).

Other insiders filing for KIORA PHARMACEUTICALS INC (KPRX)

Lane Keith J., Officer
Tosca Melissa, CFO
Stengone Carmine N., Director
Shapiro Aron, Director
Parsons Erin, Director
Hollander David, Director

How to read Form 4 transaction codes